Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Weekly injection (or daily pill) for diabetes and weight loss. | Weekly dual-hormone injection with the largest weight loss of any approved drug. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | GLP-1 receptor agonists | Dual GIP/GLP-1 agonists |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Type 2 diabetes, Obesity and overweight with health problems, Reducing heart attack and stroke risk, Kidney disease in type 2 diabetes, MASH (fatty liver inflammation) | Type 2 diabetes, Obesity and overweight with health problems, Obstructive sleep apnoea with obesity |
| How it works | Copies a gut hormone that boosts insulin after meals, slows the stomach and makes you feel full. | Copies two gut hormones that control insulin, appetite and fat storage. |
| Starts working | Appetite falls within days; full effect over months | — |
| Half-life | About 1 week | About 5 days |
| Typical adult dose | Ozempic: 0.25 mg weekly, increased monthly to 0.5–2 mg. Wegovy: increased over 16 weeks to 2.4 mg weekly. Rybelsus: 3 mg rising to 7–14 mg daily, on an empty stomach with a sip of water. | Start 2.5 mg weekly, increasing by 2.5 mg every 4 weeks to 5–15 mg. |
| Forms | Weekly pen injection, Daily tablet | Weekly pen or vial injection |
| Common side effects | Nausea, Vomiting, Diarrhoea, Constipation, Reflux, Tiredness | Nausea, Diarrhoea, Vomiting, Constipation, Reduced appetite |
| Serious side effects | Pancreatitis, Gallstones, Dehydration and kidney injury from vomiting, Worsening diabetic eye disease with rapid sugar falls, Optic nerve damage (NAION, very rare), Aspiration during anaesthesia | Pancreatitis, Gallbladder disease, Dehydration and kidney injury, Aspiration under anaesthesia |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Usually avoidedStop at least 2 months before trying to conceive. | Usually avoidedStop at least 1 month before trying to conceive. |
| Breastfeeding | — | — |
| In use since | 2017 | 2022 |
| Brand names | United States: Ozempic, Wegovy, RybelsusUnited Kingdom: Ozempic, Wegovy, RybelsusIndia: Ozempic, Wegovy, Rybelsus | United States: Mounjaro, ZepboundUnited Kingdom: MounjaroIndia: Mounjaro |
| Legal status | — | — |
| ATC code | A10BJ06 | A10BX16 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker